drugset / Trial / NCT00043303
Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis
RandomizedSingle-groupQuadruple-blindTreatment
Summary
The purpose of this research study is to test the safety and effectiveness of Interferon gamma-1b (IFN-g 1b) injected subcutaneously (under the skin) for the treatment of advanced liver fibrosis and cirrhosis in patients with chronic hepatitis C infections. IFN-g 1b is not currently approved for the treatment of liver fibrosis.
Timeline
- Start
- 2001-09
- Primary completion
- —
- Completion
- 2003-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Interferon gamma-1b | Protein / enzyme biologic | 100 ug | Subcutaneous |
| Subject | Interferon gamma-1b | Protein / enzyme biologic | 200 ug | Subcutaneous |